Selling, General, and Administrative Costs: Catalent, Inc. vs Walgreens Boots Alliance, Inc.

SG&A Expenses: Catalent vs Walgreens Boots Alliance

__timestampCatalent, Inc.Walgreens Boots Alliance, Inc.
Wednesday, January 1, 201433480000017992000000
Thursday, January 1, 201533730000022400000000
Friday, January 1, 201635810000023910000000
Sunday, January 1, 201740260000023813000000
Monday, January 1, 201846260000024694000000
Tuesday, January 1, 201951200000023557000000
Wednesday, January 1, 202057790000025436000000
Friday, January 1, 202168700000024586000000
Saturday, January 1, 202284400000027295000000
Sunday, January 1, 202383100000034205000000
Monday, January 1, 202493500000028113000000
Loading chart...

Unleashing the power of data

A Comparative Analysis of SG&A Expenses: Catalent, Inc. vs Walgreens Boots Alliance, Inc.

In the ever-evolving landscape of corporate finance, understanding the nuances of Selling, General, and Administrative (SG&A) expenses is crucial. Over the past decade, Catalent, Inc. and Walgreens Boots Alliance, Inc. have showcased contrasting trajectories in their SG&A expenditures. From 2014 to 2024, Catalent's SG&A costs have surged by approximately 179%, reflecting its aggressive expansion and operational scaling. In contrast, Walgreens Boots Alliance, with its vast retail footprint, has maintained a more stable growth, with a 59% increase over the same period.

This divergence highlights the strategic differences between a pharmaceutical manufacturing giant and a retail behemoth. While Catalent's expenses grew from $334 million to $935 million, Walgreens Boots Alliance's expenses rose from $17.7 billion to $28.1 billion. This data not only underscores the scale of operations but also the strategic priorities of these industry leaders.

Published by
U.S. Securities and Exchange Commission

Source link
sec.gov

Date published
17 Jan 2025